The impact of breakthrough clinical trials on survival in population based tumor registries
Authors:
- Larry G. KesslerLKLarry G. Kessler
- Stuart G. BakerSBStuart G. Baker
- Helen E. TrioloHTHelen E. Triolo
- Donald T. GreenDGDonald T. Green
- 1 January 1991
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 44 (2) , 141-153
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Progress and objectives in cancer control1988
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- Progress against Cancer?New England Journal of Medicine, 1986
- The Treatment of Diseases and the War against CancerScientific American, 1985
- BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP RegimenAnnals of Internal Medicine, 1984
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lectureCancer, 1981
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- Mithramycin therapy in advanced testicular neoplasmsCancer, 1970
- Combined Vinblastine and Chlorambucil Therapy of Hodgkin's DiseaseAnnals of Internal Medicine, 1965
- Effects of Combined Drug Therapy on Metastatic Cancer of the TestisJAMA, 1960